Literature DB >> 8283495

Sensitivity of multiple myeloma to imexon in the human tumor cloning assay.

S E Salmon1, E M Hersh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8283495     DOI： 10.1093/jnci/86.3.228

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Anti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423.

Authors:  Robert T Dorr; Lee Wisner; Betty K Samulitis; Terry H Landowski; William A Remers
Journal:  Cancer Chemother Pharmacol       Date:  2011-12-21       Impact factor: 3.333

2.  Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell lines.

Authors:  Robert T Dorr; Mary Ann Raymond; Terry H Landowski; Nicholas O Roman; Shoji Fukushima
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Multiple myeloma: VI International Workshop, June 14-18, 1997, Boston, Massachusetts, USA.

Authors:  S Bergenbrant
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

4.  Preclinical pharmacokinetics and antitumor activity of imexon.

Authors:  R T Dorr; J D Liddil; M K Klein; E M Hersh
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

5.  The antitumor agent imexon activates antioxidant gene expression: evidence for an oxidative stress response.

Authors:  Amanda F Baker; Terry Landowski; Robert Dorr; Wendy R Tate; Jaime M C Gard; Breonna E Tavenner; Tomislov Dragovich; Amy Coon; Garth Powis
Journal:  Clin Cancer Res       Date:  2007-06-01       Impact factor: 12.531
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.